Time-to-onset analysis using the Weibull distribution test.

<p>Time-to-onset analysis using the Weibull distribution test.</p>

Gorde:

Xehetasun bibliografikoak
Egile nagusia:	Jun Hua Lai (22676523) (author)
Beste egile batzuk:	Yi Ping Pan (22676526) (author), Zhi Hui Yu (22676529) (author), Wen Fang Jang (22676532) (author), Jun Tao Hu (22676535) (author), Zhan Hong Tang (22676538) (author)
Argitaratua:	2025
Gaiak:	Cell Biology Pharmacology Biotechnology Science Policy Mental Health Infectious Diseases reporting odds ratio increased vascular permeability elucidating risk factors compromised gas exchange 86 %), followed study analyzed data identify ade signals prr ), chi drug nomenclature using reported ards population patients requiring hospitalization onset analysis demonstrated induced adverse events enhance patient safety ades occurred within term outcomes associated median onset time first 30 days xlink "> drug xlink "> patient safety study highlights severe outcomes median age induced ards first quarter adverse event ade management ic ), ebgm ), drug dictionaries drug administration united states underlying mechanisms timely intervention targeted ades substantial implications significant morbidity reports originated regulatory activities pulmonary edema prior studies medical dictionary information component inflammatory cascades future research fourth quarter findings revealed endothelial dysfunction disproportionality analyses
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak